Delve Bio launched Delve Detect Plasma, a blood-based mNGS assay that detects over 68,000 pathogens with next-day results, ...
Biotechnology firm INmune Bio Inc. (NASDAQ: INMB) and photonic quantum developer Quantum Computing Inc. (NASDAQ: QUBT) have ...
In an industry-first convergence of quantum photonics and precision medicine, INmune Bio Inc. (NASDAQ: INMB) and Quantum Computing Inc. (NASDAQ: QUBT) have entered into a commercial collaboration to ...
INmune Bio and Quantum Computing Inc. partner to explore how AI and quantum computing can advance Alzheimer's drug research.
Rahmeh Aladwan is a doctor in the U.K. She's also a Muslim, and it seems those two things are a contradiction, especially ...
13h
Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
("LarmorBio") today announced that Velocity Bioworks, Valion's wholly owned biologics contract development and manufacturing ...
The project covers a secure knowledge vault, AI agents and access controls; delivery is scheduled by Dec. 15, subject to Bio ...
South Korea's government is advancing the National Integrated Bio Big Data Project, which aims to collect genomic and health information from ...
Quantum computing expands into pharma as INmune Bio and Quantum Computing Inc. partner to advance Alzheimer’s drug research ...
INmune Bio and QCi will test quantum optimization and AI to explore potential new uses for XPro, an investigational treatment ...
Niki BioSolutions, Inc. announced that its wholly owned subsidiary, DiamiR Biosciences Corp. (?DiamiR?), will perform apolipoprotein E (APOE) genotyping on plasma samples from the Global Alzheimer?s ...
INmune Bio Inc. ( INMB) and Quantum Computing Inc. (QUBT) announced a collaboration to apply quantum computing, artificial intelligence and data analytics to identify new potential applications for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results